Methods for treating multiple sclerosis using antisense oligonucleotides

Details for Australian Patent Application No. 2009271678 (hide)

Owner Antisense Therapeutics Limited Teva Pharmaceutical Industries, Ltd.

Inventors Diamond, Mark Paul; Tachas, George; Tessler, Shoshi; Klinger, Ety; Hallak, Hussein

Agent FB Rice

Pub. Number AU-A-2009271678

PCT Pub. Number WO2010/008474

Priority 61/132,973 23.06.08 US

Filing date 23 June 2009

Wipo publication date 21 January 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/008474 Priority application(s): WO2010/008474

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009271680-Methods to increase crop yield

2009271675-Pest control devices, methods, and apparatus